However, if youre taking other diabetes medications, particularly insulin or sulfonylureas, the risk increases
Enzo MV, Rastrelli M, Rossi CR, Hladnik U, Segat D (2015) The Wnt/-catenin pathway in human fibrotic like diseases and its eligibility as a therapeutic target
22% weight loss at 36 weeks with no plateau is strong, but Phase 3 at longer durations will tell us where it truly lands
Contact Us Melanotan II is a synthetic cyclic heptapeptide analogue of -melanocyte-stimulating hormone (-MSH), engineered for enhanced receptor affinity and metabolic stability
Some clinicians report that patients can achieve and maintain weight loss at lower doses but these observations lack formal scientific validation
If youre considering tirzepatide drops as an alternative, the evidence gap is the same